Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cells
- 1 January 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 185, 111809
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 31 references indexed in Scilit:
- Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing oxazole or imidazole as potential EGFR inhibitorsNew Journal of Chemistry, 2018
- Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitorsComputational and Structural Biotechnology Journal, 2018
- Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitorsBioorganic & Medicinal Chemistry, 2017
- EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinomaOncoTargets and Therapy, 2015
- Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)Drug Design, Development and Therapy, 2010
- The PI3K Pathway As Drug Target in Human CancerJournal of Clinical Oncology, 2010
- Targeting protein kinases in central nervous system disordersNature Reviews Drug Discovery, 2009
- EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic TreatmentJournal of Clinical Oncology, 2005
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002